Terms: = Leukemia AND TPM3, ENSG00000143549, 7170 AND Treatment
3 results:
1. Influencing factors of anthracycline-induced subclinical cardiotoxicity in acute leukemia patients.
Zhou X; Weng Y; Jiang T; Ou W; Zhang N; Dong Q; Tang X
BMC Cancer; 2023 Oct; 23(1):976. PubMed ID: 37833648
[TBL] [Abstract] [Full Text] [Related]
2. Infantile fibrosarcoma with tpm3-NTRK1 fusion in a boy with Bloom syndrome.
Huson SM; Staab T; Pereira M; Ward H; Paredes R; Evans DG; Baumhoer D; O'Sullivan J; Cheesman E; Schindler D; Meyer S
Fam Cancer; 2022 Jan; 21(1):85-90. PubMed ID: 33219493
[TBL] [Abstract] [Full Text] [Related]
3. Conditional tpm3-ALK and NPM-ALK transgenic mice develop reversible ALK-positive early B-cell lymphoma/leukemia.
Giuriato S; Foisseau M; Dejean E; Felsher DW; Al Saati T; Demur C; Ragab A; Kruczynski A; Schiff C; Delsol G; Meggetto F
Blood; 2010 May; 115(20):4061-70. PubMed ID: 20223922
[TBL] [Abstract] [Full Text] [Related]